Quality standards in respiratory real-life effectiveness research: the REal Life EVidence AssessmeNt Tool (RELEVANT): report from the Respiratory Effectiveness Group—European Academy of Allergy and Clinical Immunology Task Force-Reference-Cited by-同舟云学术

Quality standards in respiratory real-life effectiveness research: the REal Life EVidence AssessmeNt Tool (RELEVANT): report from the Respiratory Effectiveness Group—European Academy of Allergy and Clinical Immunology Task Force

Published:2019-03-27 Issue:1 Volume:9 Page:
ISSN:2045-7022
Container-title:Clinical and Translational Allergy
language:en
Short-container-title:Clin Transl Allergy

Author:

Roche Nicolas,Campbell Jonathan D.,Krishnan Jerry A.,Brusselle Guy,Chisholm Alison,Bjermer Leif,Thomas Mike,van Ganse Eric,van den Berge Maarten,Christoff George,Quint Jennifer,Papadopoulos Nikolaos G.,Price David

Funder

European Academy of Allergy and Clinical Immunology

Respiratory Effectiveness Group

Publisher

Wiley

Subject

Immunology and Allergy,Immunology,Pulmonary and Respiratory Medicine

Link

http://link.springer.com/content/pdf/10.1186/s13601-019-0255-x.pdf

Reference97 articles.

1. Roche N, Reddel HK, Agusti A, Bateman ED, Krishnan JA, Martin RJ, et al. Integrating real-life studies in the global therapeutic research framework. Lancet Respir Med. 2013;1(10):e29–30.

2. Lisspers K, Teixeira P, Blom C, Kocks J, Ställberg B, Price D, et al. Are pharmacological randomised controlled clinical trials relevant to real-life asthma populations? A protocol for an UNLOCK study from the IPCRG. NPJ Prim Care Respir Med. 2016;26:16016.